News AZ strikes COPD deal with Circassia, suffers setback with bl... FDA rejects blood potassium drug for second time.
News Good news for GSK’s next generation asthma drug Results mean patients could switch to once-daily inhaler use
News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
Views & Analysis Collaboration the key to success in respiratory research Lung research needs support as fifth of UK diagnosed with respiratory condition.
News Use generic alternatives to Seretide and save millions, advi... Earlier use of montelukast could save NHS millions, says NICE.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.